At December 31, 2004 and 2003 (in thousands) |
2004 |
2003 |
|---|---|---|
Assets: |
||
Cash and cash equivalents |
$220,836 |
$190,837 |
Receivable on pending securities transactions |
13,595 |
32,875 |
Interest and dividends receivable |
7,771 |
8,703 |
Contributions receivable |
11,378 |
10,131 |
Investments at fair value |
||
Johnson & Johnson common stock |
4,438,494 |
4,158,589 |
Other equity investments |
3,249,619 |
2,586,726 |
Fixed income investments |
970,876 |
872,558 |
Program related investments |
9,672 |
10,076 |
Other assets |
60,591 |
63,266 |
Total assets |
$8,982,832 |
$7,933,761 |
Liabilities and Net Assets |
|
|
Liabilities: |
|
|
Accounts payable and accrued expenses |
$19,721 |
$6,172 |
Payable on pending securities transactions |
77,324 |
86,750 |
Unpaid grants |
444,510 |
571,784 |
Deferred federal excise tax |
96,640 |
87,913 |
Accrued postretirement benefit obligation |
11,755 |
9,899 |
Total liabilities |
649,950 |
762,518 |
Net assets: |
|
|
Unrestricted |
8,321,504 |
7,161,112 |
Temporarily restricted |
11,378 |
10,131 |
Total net assets |
8,332,882 |
7,171,243 |
Total liabilities and net assets |
$8,982,832 |
$7,933,761 |
|
|